PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.772
https://www.valueinhealthjournal.com/article/S1098-3015(18)34072-5/fulltext
Section Title :
Section Order :
172
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34072-5&doi=10.1016/j.jval.2018.09.772